Padlock Therapeutics Director of Business Development Salary
The average Padlock Therapeutics Director of Business Development earns an estimated $197,675 annually, which includes an estimated base salary of $140,925 with a $56,750 bonus. Padlock Therapeutics' Director of Business Development compensation is $31,373 more than the US average for a Director of Business Development. Director of Business Development salaries at Padlock Therapeutics can range from $113,767 - $260,000.
The Business Development Department at Padlock Therapeutics earns $1,671 more on average than the Legal Department.
Last updated 5 years ago.
- $140,925
- avg. base
- $56,750
- avg. bonus
Director of Business Development Salaries at Padlock Therapeutics
Directors of Business Development earn $6,478 more than Directors of Business Development.
Compensation at Padlock Therapeutics by Department
The Business Development Department averages $1,671 more than the Legal Department, and $3,487 less than the HR Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Padlock Therapeutics reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Padlock Therapeutics reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Padlock Therapeutics Rate Their Compensation
The majority of Directors of Business Development at Padlock Therapeutics believe they're compensated fairly. 50% of Directors of Business Development at Padlock Therapeutics say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Padlock Therapeutics
